Table 5.
Compound | Rt (min) | Formula | [M–H]− measured (m/z) | Main fragments MS2 [M–H]− (m/z) | Relative abundance (%) |
---|---|---|---|---|---|
Caffeic acid derivative | 6.8 | C18H18O9 | 377.0883 | 341.1071–191.0582–179.0358 | ++ |
Hydroxytyrosol glucoside | 11.2 | C14H20O8 | 315.1140 | naa | +++ |
Elenolic acid glucoside | (i) 12.1 | C17H24O11 | 403.1356 | 223.0633–371.0979 | (i) ++++ |
(ii) ++++ | |||||
(iii) ++++ | |||||
(ii) 13.3 | |||||
(iii) 13.6 | |||||
Epigallocatequin | 13.2 | C15H14O7 | 305.0782 | 125.1182 | ++ |
Neo-Nüzhenide isomers | (i) 13.8 | C31H42O18 | 701.2298 | 523.1820–315.1123–403.1233 | (i) +++ |
(ii) +++ | |||||
(ii) 14.2 | |||||
Verbascoside | 14.0 | C29H36O15 | 623.2096 | 461.1647 | ++ |
Nüzhenide isomers | (i) 14.1 | C31H42O17 | 685.2338 | 523.1830–299.1190 | (i) ++++ |
(ii) ++++ | |||||
(ii) 15.8 | |||||
Oleuropein aglycon | 15.3 | C16H26O10 | 377.1215 | 195.0666 | +++ |
Methoxynüzhenide | 16.6 | C32H44O18 | 715.2455 | 523.1736–553.1927–329.1241 | ++ |
Tyrosol glucoside | 18.1 | C14H20O7 | 299.1180 | na | +++ |
Nüzhenide 11-methyloleoside isomers | (i) 18.8 | C48H64O27 | 1071.3551 | 685.2397–771.2381–523.1873–403.1231 | (i) + |
(ii) ++ | |||||
(iii) ++ | |||||
(iv) + | |||||
(ii) 21.3 | |||||
(iii) 23.2 | |||||
(iv) 23.7 | |||||
Apigenin rutinoside | 19.2 | C27H30O14 | 577.1579 | na | + |
Oleuropein | 19.8 | C25H32O13 | 539.1851 | 377.1215–307.0838–275.0949 | ++++ |
Ligstroside | 21.9 | C25H32O12 | 523.1841 | 291.0896–361.1304 | +++ |
Demethyloleuropein | 23.5 | C24H30O13 | 525.1982 | 405.13–291.09 | ++++ |
Jaspolyanoside | 24.1 | C42H54O22 | 909.3192 | 523.1843–361.1289–291.0881 | ++ |
Luteolin | 24.3 | C15H10O6 | 285.0402 | na | ++ |
Compounds are listed on the basis of increasing retention times (Rt)
Relative abundance (% precursor ion intensity) of the metabolites identified is indicated by + (0–5%), ++ (5–20%), +++ (20–50%) and ++++ (50–100%)
ana not available